Medical devices: how to comply with legal requirements in Great Britain

AI Summary

This guidance document from the UK Medicines and Healthcare products Regulatory Agency (MHRA) outlines the mandatory regulatory framework for medical devices in Great Britain under the Medical Devices Regulations 2002 (UK MDR 2002) and the Consumer Protection Act 1987. The guidance applies to all manufacturers intending to market general medical devices, active implantable devices, or in vitro diagnostic (IVD) products. Devices are classified by risk level, ranging from Class I (low risk) to Class III (high risk). Key requirements for compliance include mandatory registration of all devices with the MHRA and the completion of conformity assessments. For moderate to high-risk devices, manufacturers must involve a UK Approved Body to evaluate clinical data and quality management systems before applying the UKCA mark. Manufacturers are also required to maintain robust clinical evidence and provide notification of clinical investigations at least 60 days in advance. Furthermore, the guidance emphasizes the importance of post-market surveillance and reporting serious adverse incidents. Notably, new legislation to strengthen these surveillance requirements will take effect on June 16, 2025, aimed at improving incident traceability and risk management. Required actions for manufacturers include determining correct device classification, ensuring conformity through approved bodies where necessary, and adhering to strict reporting and registration timelines to ensure products are acceptably safe for their intended purpose.